In a recent blog Dr Mark Packer said: “Somewhere in the back of my mind I keep a quote about perseverance and simplicity. It comes from an interview with Ernest Hemingway. The author was asked to explain why he rewrote the last page of A Farewell to Arms 39 times.”
Get the most out of your stay in Paris by looking out for OTEurope?s City Guide. We recommend the best restaurants, bars and cafés to visit and the sights not to be missed.
Researchers at the University of Massachusetts Medical School (UMMS) believe they may have found a new treatment for retinitis pigmentosa (RP), a severe neurodegenerative disease of the retina that ultimately results in blindness.
OTEurope's guide to Paris...
Hoya has formed a strategic partnership with Adoptics of Switzerland by funding the development of a shape-changing accommodating intraocular lens (AIOL).
Findings published in the July/August edition of Retina contain the results of a Phase II trial indicating that microplasmin was generally well tolerated, and support its potential for nonsurgical resolution of vitreomacular adhesion
Glaucoma patient and director of the movie Going Blind, Joe Lovett and his team have developed a comprehensive Outreach Toolkit with details on how doctors can use the film to raise awareness of funding, educate students and patients or promote themselves.
The European Commission's independent Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) is seeking the assistance of ophthalmic experts who are interested in helping with its Health Effects Of Artificial Light working group.
Findings in the July issue of the Archives of Ophthalmology have indicated that silicon oil may safeguard patients'eyesight when undergoing radiation therapy for ocular melanoma.
The American Academy of Ophthalmology (AAO) has issued a warning about the harm decorative circle lenses used by Lady Gaga in a recent video.
The Glaucoma Research Foundation has received the largest single gift in its 32 year history. The staggering $1.6 million gift from the Melza M. and Frank Theodore Barr Foundation and is to support the ongoing research of the Catalyst For a Cure consortium to discover a cure for glaucoma.
In Spain, the first product based on interference RNA (RNAi) technology is an ophthalmic treatment in the form of drops to treat elevated IOP and glaucoma. SYL040012 has just completed its first clinical trial, having been administered to 30 healthy volunteers.
Professor Ye-Guo Chen, one of the top five key opinion leaders in Chinese refractive surgery has demonstrated a drastic improvement in flap thickness and planarity when using the One Use-Plus SBK microkeratome, defined as 'Sub Bowman's Keratomileusis. '
VisionCare&#;s implantable telescope for end-stage AMD has finally been given FDA approval. The device, discussed in depth in Ophthalmology Times Europe July 2007, was given CE approval three years ago but has subsequently been undergoing rigorous clinical trials in the United States.
With automatic and non-contact measurement of the patient's eye, the new IOLMaster 500 offers the fastest and easiest way of calculating the right IOL for each patient.
In its continuing quest to play a part in every step of the cataract procedure Alcon is to acquire LenSx Lasers Inc., for $361.5 million in cash
As editor of Ophthalmology Times Europe I would like to hear your views about choices you make on behalf of your patients.
British and German scientists Dr Claus Cursiefen and his colleagues have reported that transplanted corneas are more likely to fail or be rejected in patients whose eyes exhibit abnormal vessel growth, called corneal neovascularization, before surgery.
Ophthalmic Women Leaders (OWL) and Women In Ophthalmology, Inc. (WIO) are pleased to announce their joint partnership in presenting the WIO Summer Symposium.
Just one of the themes delegates at this year's congress can explore.
For neovascular AMD sufferers, this combination therapy may offer an alternative to continual anti-VEGF injections
Applications in ophthalomology include gene delivery, cell delivery and nanosurgery.
Glaucoma is a final pathway of amny different disorders that can lead to a common pattern of optic nerve and visual field damage
Some of the products that company's will shoiwcase at this year's ESCRS.
12-month data from the BOLT study provides supporting evidence for the use of bevacizumab in patients with clinically significant DME.
An holistic approach that focuses on the healthy part of the cornea.
Innovative pharmacological approaches investigated in haze prevention research
Investigating the tolerability and IOP reduction effect of switching from latanoprost to tafluprost in patients exhibiting ocular surface side effects
At WOC 2010 there were 738 sessions and 1120 posters and over 13,000 people attended the Congress. OTEurope brings you a selection of Berlin highlights.
The French EyeOP1 medical device, from EyeTechCare, is a novel and non-invasive treatment for glaucoma that is based on the use of high-intensity focused ultrasound (HIFUs). The product is set to become available at the end of 2010